Skip to content

Search results for : Cancer

Movement to End Medical Mistakes

President Clinton and congressional lawmakers are concerned with recent reports of deadly medical errors.Fueled by last weeks report that medical mistakes kill thousands of Americans, President Clinton and congressional lawmakers are putting together plans to quickly reduce the number of deaths from medical error. Here are two sources for this article:ABC NewsNando Media (Printer Friendly)Update:Moral

Read More »

Dr. Ian Grassam – In Loving Memory

On Friday morning, November 26th, Ian Grassam passed away. He fought his greatest battle, against cancer, and finally decided to give it up and leave us in body and soul, to go home to be with our Heavenly Father. He was one of the greatest warriors and teachers for principled chiropractic. He fought political battles

Read More »

Experts highlight technologies that will revolutionize medicine

On Thursday, the British Medical Journal made their predictions as to what the future of medicine would be. These are the future “miracles” of medicine.“Picture a world where wheelchairs can climb stairs and insulin sacs implanted in diabetics automatically release just the right amount at the right time.”“Cures aren’t really our final destination,” said Dr.

Read More »

Drug company-sponsored studies less critical than independent studies

CHICAGO (AP) – Studies on the cost-effectiveness of drugs are far more likely to report favorable findings if they are sponsored by the drug companies themselves rather than independent groups, researchers found. Their study – funded by a pharmaceutical company – appears to confirm long-held suspicions that doctors are less critical about a drug’s safety

Read More »

More off-label drug promotion in the offing

Though the full impact of a recent federal court ruling is unclear, doctors can expect more off-label drug use information from drug manufacturers. Washington — Eli Lilly announced this month that it would direct its sales representatives to market its osteoporosis drug, Evista (raloxifene), as a breast cancer prevention agent.This step was noteworthy for two

Read More »

Movement to End Medical Mistakes

President Clinton and congressional lawmakers are concerned with recent reports of deadly medical errors.Fueled by last weeks report that medical mistakes kill thousands of Americans, President Clinton and congressional lawmakers are putting together plans to quickly reduce the number of deaths from medical error. Here are two sources for this article:ABC NewsNando Media (Printer Friendly)Update:Moral

Read More »

Dr. Ian Grassam – In Loving Memory

On Friday morning, November 26th, Ian Grassam passed away. He fought his greatest battle, against cancer, and finally decided to give it up and leave us in body and soul, to go home to be with our Heavenly Father. He was one of the greatest warriors and teachers for principled chiropractic. He fought political battles

Read More »

Experts highlight technologies that will revolutionize medicine

On Thursday, the British Medical Journal made their predictions as to what the future of medicine would be. These are the future “miracles” of medicine.“Picture a world where wheelchairs can climb stairs and insulin sacs implanted in diabetics automatically release just the right amount at the right time.”“Cures aren’t really our final destination,” said Dr.

Read More »

Drug company-sponsored studies less critical than independent studies

CHICAGO (AP) – Studies on the cost-effectiveness of drugs are far more likely to report favorable findings if they are sponsored by the drug companies themselves rather than independent groups, researchers found. Their study – funded by a pharmaceutical company – appears to confirm long-held suspicions that doctors are less critical about a drug’s safety

Read More »

More off-label drug promotion in the offing

Though the full impact of a recent federal court ruling is unclear, doctors can expect more off-label drug use information from drug manufacturers. Washington — Eli Lilly announced this month that it would direct its sales representatives to market its osteoporosis drug, Evista (raloxifene), as a breast cancer prevention agent.This step was noteworthy for two

Read More »